Latest News in the pharma Industry

Market News

The Safelia autoinjector wins the ‘Exhibitor Innovation’ Award at Pharmapack

The Safelia autoinjector wins the ‘Exhibitor Innovation’ Award at Pharmapack

5 Feb 2017

A team of industry experts reward Nemera’s autoinjector with a Pharmapack Award as best innovation product.

Read more 
FDA approves BMS's Opdivo for bladder cancer

FDA approves BMS's Opdivo for bladder cancer

5 Feb 2017

Opdivo has now been approved in six tumour types in just over 2 years.

Read more 
Reach Separations celebrates 5th birthday with record year

Reach Separations celebrates 5th birthday with record year

3 Feb 2017

The company’s growth has been driven by export, with a three-fold increase in activity outside of the UK during 2016,

Read more 
Leukocare signs up to become Rentschler's specialized tech partner and formulation developer

Leukocare signs up to become Rentschler's specialized tech partner and formulation developer

2 Feb 2017

Rentschler will become the first and only CDMO to have access to Leukocare's patented SPS formulation technologies.

Read more 
KBI Biopharma expands services, including cell therapy manufacturing, through acquisition

KBI Biopharma expands services, including cell therapy manufacturing, through acquisition

2 Feb 2017

Acquisition provides fully equipped facilities for the development and manufacture of clinical stage cellular therapy products, including three ISO7 cGMP manufacturing suites, extensive flow cytometry and analytical infrastructure.

Read more 
Aralez Pharmaceuticals unveils new office in Ireland

Aralez Pharmaceuticals unveils new office in Ireland

2 Feb 2017

The Dublin offices are the company's first permanent business premises outside of North America.

Read more 
EPO upholds decision regarding Sprycel

EPO upholds decision regarding Sprycel

1 Feb 2017

Patent found to be invalid.

Read more 
Allergan successfully completes LifeCell acquisition

Allergan successfully completes LifeCell acquisition

1 Feb 2017

Acquisition creates world-class aesthetic and regenerative medicine business in plastic surgery.

Read more 
Biogen completes separation of global hemophilia business, Bioverativ

Biogen completes separation of global hemophilia business, Bioverativ

1 Feb 2017

Bioverativ common stock to be traded on the NASDAQ global select market.

Read more 
Sanofi's Xyzal Allergy 24HR approved for OTC use in the US

Sanofi's Xyzal Allergy 24HR approved for OTC use in the US

1 Feb 2017

Xyzal is an oral antihistamine with a proven 24-hour effect.

Read more 
Mylan wins US District Court ruling related to Copaxone 40 mg/mL patents

Mylan wins US District Court ruling related to Copaxone 40 mg/mL patents

31 Jan 2017

Patents in question invalidated based on obviousness.

Read more 
IBA Molecular acquires Mallinckrodt nuclear imaging to create world-class radiopharmaceuticals group

IBA Molecular acquires Mallinckrodt nuclear imaging to create world-class radiopharmaceuticals group

31 Jan 2017

The enlarged business will comprise 21 manufacturing centres and commercial operations across 60 countries.

Read more